chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Problems with my thigh started about 6 weeks ago and finally they are getting worse; Something is going on with the back of my thigh it's  difficult to walk; This is a spontaneous report from two contactable consumers (Patient and another consumer).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: EN6207), dose 2 via an unspecified route of administration, in Right arm on 16Mar2021 at 13:00 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot number: EL9267), dose 1 via an unspecified route of administration in right arm on 23Feb2021 at 13:00 for COVID-19 immunization. Patient did not receive prior vaccination within 4 weeks. On an unspecified date in 2021, Consumer stated that consumer was having side effects from the Pfizer vaccine. Consumer read online some of the problems were in your thighs and consumer thought consumer had formed hamstring in both thighs and consumer just went to have an x-ray in hamstrings were fine but there was something was going on with the back of thigh it's difficult to walk. The problems with thigh started about 6 weeks ago and finally they were getting worse on an unspecified date in Jun2021 and consumer went to doctor 3 days ago. Patient did not receive any treatment for side effects. The patient underwent lab tests and procedures on an unspecified date in 2021 which included x-ray: fine (x-ray in my hamstrings are fine). The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Patient experienced some bleeding at the injection site and within a minute after IMZ a moderate size knot developed at injection site along with some bruising. Patient stated no soreness at site or no shortness of breath.
Bloody nose for a hour. about 6 hours after shot haven't had a bloody nose in years; is bivalent True/dose number: 1; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Dec2022 at 12:15 as dose 1 (bivalent), single (Batch/Lot number: unknown) at the age of 44 years, in right arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history included: "High BP" (unspecified if ongoing), notes: High BP; "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. There were no concomitant medications. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 21Dec2022 at 12:15, outcome "unknown", described as "is bivalent True/dose number: 1"; EPISTAXIS (non-serious) with onset 21Dec2022 at 18:00, outcome "unknown", described as "Bloody nose for a hour. about 6 hours after shot haven't had a bloody nose in years". It was unknown if therapeutic measures were taken as a result of epistaxis. Additional information: the patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
SICK; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a consumer via a company representative via social media concerned multiple patients (2) of an unspecified age, sex, race and ethnicity.   The patient's weight, height, and medical history were not reported. On an unspecified date, the patients previously received 2 doses with covid-19 vaccine from unspecified manufacturer (form of admin, route of admin, and batch number and expiry date were not reported), dose was not reported (dose number in series 1), for covid-19 prophylaxis. It was unknown whether patients had any adverse event following covid-19 vaccine from unspecified manufacturer (dose number in series 1). The patients received third dose with covid-19 vaccine ad26.cov2.s (unspecified manufacturer), (dose number in series 2), (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis which was a revaccination with different covid-19 vaccine (dose number in series 2). The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced sick (dose number in series 2). It was reported as "My ENTIRE fam has had 1,2,3x's-that's extended fam-their kids-2 teens. ALL jabbed- All sick now" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sick, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20221210598, 20221210961, 20221211116, 20221212903 and 20221210980.
Small "knot" developed shortly after injection. Patient expected this as he experienced a knot after other anthrax vaccines. The knot improved but didn't disappear. Approximately 3 weeks later, patient developed nausea, fatigue and malaise approximately 1 hour after eating. His wife discovered an "eraser-sized bubble" on his arm at the injection site. The area was swollen, tender and itchy. Patient went to Emergency Room and was told to take Ibuprofen and Benadryl. He felt better after taking medication and fully recovered within a day or two.
This case was reported by a physician via call center representative and described the occurrence of necrosis in a female patient who received CERVARIX. On an unknown date, the patient received CERVARIX at an unknown dose. On an unknown date, unknown after receiving CERVARIX, the patient experienced necrosis (serious criteria GSK medically significant) and hypercoagulation. On an unknown date, the outcome of the necrosis and hypercoagulation were unknown. It was unknown if the reporter considered the necrosis and hypercoagulation to be related to CERVARIX. Additional details provided as follows: The reporter said that one of her patient's was told at the hospital by top doctors that HPV vaccine caused hypercoagulation causing her to have a necrosed foot. They said it could be that the vaccine caused her to have aluminum toxicity.
right knee pain and swelling starting 2 days after vaccination. no prior history of gout. no falls or trauma to the area. was off of prior rx of HCTZ at the time. has not been aspirated. did not respond to acetaminophen, NSAIDs, or tramadol. has improved by about 50% and on exam today no sign of meniscal tear or cartilage injury, preserved range of motion and 1-2+ effusion without warmth or erythema to the right knee. walks with little difficulty.
In April of 2021 I received my first dose of Moderna, followed by my second dose 4 weeks later. That summer I lost some weight without trying, but was not alarmed. In November 2021 I received a booster dose of Moderna. Approximately 6 weeks later I started to experience my first symptoms of what would later be diagnosed as Type I Diabetes. I experienced rapid weight loss, losing over 40 pounds in 5 months. I was constantly thirsty, frequently going to the bathroom, and constantly exhausted.   I saw a primary care physician for a physical in mid-May, where he detected extremely elevated cholesterol levels, despite my BMI to be low. I referred to  a cardiologist (Dr.), and the lab results from her tests detected extremely high blood sugar and abnormal urine analysis. I was then told to immediately check into the Emergency Room at a local Hospital. There I was properly diagnosed with T1D.
Reactions to COVID-19 Vaccine:  (immediately) tingling and numbness in tongue, a little pain &  swelling in tongue, Burning eyes, headache ... (Next Day) severe headache, severe tinnitus, Sore arm, tongue feels strange, severe fatigue, severe nausea ... (Friday) headache, severe tinnitus, tongue feels strange,  fatigue, breathless,  nausea ... (Sat) headache, severe tinnitus, tongue feels strange, fatigue, nausea.
Information has been received from a registered nurse concerning a 12 month old female with no relevant medical history and no known drug allergies who on the morning of 06-Jan-2004 was vaccinated in the right thigh with a first dose of varicella virus vaccine live (lot #646310/0577N). On the morning of 06-Jan-2004 the patient was also vaccinated in the left thigh with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot #646118/0614N). There was no other concomitant medications. On 16-Jan-2004 the patient developed a rash of more than ten lesions or "spots". There was no fever. There were no diagnostic laboratory tests performed. Unspecified medical attention was sought and no treatment was prescribed. Subsequently, the patient recovered. No product quality complaint was involved. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. During 2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA Injection site pain tiredness headache stuffiness muscle pain, pain at base of head and top of neck, hip pain, knee pain chills fever (2 days at 100F) nausea dizziness itchiness
c/o temp of 104 w/hallucinations, pain @ inj site, all over achiness;fever et hallucinations lasting till mid of 15JUL98;other sx x 2 days;
Delayed skin reaction of hives easily controllable with antihistamines. Rash continued to occur for approximately a week.
pain from wrist to back/pain in the lumps when touched with hot or cold water; he has hard lumps in different spots on left side; it acts like nails in body like a nerve shock/tingling; tiny things under the skin; weakness; muscle pain; This spontaneous report was received from a consumer referring to himself, a male patient of unknown age. The patient's concurrent conditions included a heart condition and diabetes. The patient's concomitant medications included twelve unspecified medications (did not want to list them all). The patient had no drug reactions or allergies.   The patient stated that he was vaccinated with zoster vaccine live (ZOSTAVAX) from a pharmacy and had multiple side effects (he was unsure of what the name of the vaccine was and the pharmacy stated to him that "they think" it was manufactured by us). On an unknown date in September 2020, he had the first dose and had two doses total for prophylaxis (could not confirm when the second dose was given) (dose, vaccination scheme frequency, route of administration, lot # and expiration date not reported).   On an unknown date, the patient started having tiny things under the skin (skin disorder) and pain from wrist to back. He went to the endocrinologist and primary doctor where they confirmed it was a side effect of the vaccine. The patient said that now it was affecting his left side and he wanted to know what advice to do with side effects. He stated he had been suffering for eleven months with pain, he had hard lumps in different spots on left side (nodule), he had pain in the lumps when touched with hot or cold water, it acted like nails in body like a nerve shock, he had muscle pain (myalgia), he had weakness (asthenia), and he had tingling (paraesthesia). The patient's endocrinologist and primary care doctor provided no recommendations for the side effects. The outcome of the events was reported as not recovered.  The causal relationship between zoster vaccine live (ZOSTAVAX) and all the reported events was unknown.
Approx 1/2 hr after injection had some itching & redness. Body aches the night, & nausea next day. Pt seen on 9/22/10 24 hrs later. Left upper arm has 5 x 10 cm erythema slight swelling at & below injection site, moderate tenderness. Given Cephalexin 500 mg 3x/day for 7 days.
Pt vaccinated with OPV/Prohibit developed fever of 104 followed by generalized tonic - clonic seizure.
Unknowingly exposed to Covid when babysitting my 2 year old granddaughter on Friday, January 7th. My daughter-in-law is a Public Schools teacher and was exposed on either Monday, January 3rd or Tuesday, January 4th. She was home on the same day but I didn't have a lot of close contact. I did have a lot of close contact with my granddaughter when I held her and she was crying a lot. I thought it was just a case of the Terrible 2's. Later that night, my son called and told me that his wife and my granddaughter tested positive for Covid using rapid antigen tests.
09:33 AM patient c/o hives and itchiness to her arms, face, lower back and legs. B/P 120/70, pulse 98, temp 96.4. Respirations easy non labored. Rash spreading rapidly at 09:35 AM - BENADRYL 50 mg IM to right deltoid administered. Continued to monitor and observe. At 10:05 AM redness, itching and hives subsided released with supervision of a friend. Alert and awake. Instructed to follow up with physician if allergy was to flare up with any respiratory issues to call 911. Follow up next day patient reported to work.
fever last Thursday and Friday with a temperature of 100.5-.8 deg F.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever last Thursday and Friday with a temperature of 100.5-.8 deg F.) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (fever last Thursday and Friday with a temperature of 100.5-.8 deg F.). At the time of the report, PYREXIA (fever last Thursday and Friday with a temperature of 100.5-.8 deg F.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 100.5-8 (Inconclusive) temperature of 100.5-8 degrees F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medicines was not reported by reporter  Treatment caller was not sure if his father took Tylenol  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
11 hours after I received my vaccine, I developed uncontrollable shaking and chills. I spiked a fever of 102F. I experienced a  headache and pain to old joint injuries.   I took 800mg of Ibuprofen. I tried pushing fluids. Rest.
polymyalgia rheumatic; This case was reported by a consumer via call center representative and described the occurrence of polymyalgia rheumatica in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 15 days after receiving Shingrix, the patient experienced polymyalgia rheumatica (serious criteria GSK medically significant). On an unknown date, the outcome of the polymyalgia rheumatica was unknown.   It was unknown if the reporter considered the polymyalgia rheumatica to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Last year (in 2018), the patient received first dose of Shingrix.   The company advised against getting the second shot. The patient asked if she would get a reaction getting FLUAD because she had developed polymyalgia rheumatic with Shingrix. The reporter did not consent to follow-up.
More achiness; Ridiculously tired ever since the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (More achiness) and FATIGUE (Ridiculously tired ever since the second dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 030L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included VALACYCLOVIR [VALACICLOVIR] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (More achiness) and FATIGUE (Ridiculously tired ever since the second dose). The patient was treated with PARACETAMOL (TYLENOL) for Fatigue and Pain, at a dose of 1 dosage form and NAPROXEN SODIUM (ALEVE) for Fatigue and Pain, at a dose of 1 dosage form. At the time of the report, PAIN (More achiness) and FATIGUE (Ridiculously tired ever since the second dose) outcome was unknown.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lumpy Knot at injection site on my arm that hurts) and VACCINATION SITE PAIN (lumpy Knot at injection site on my arm that hurts) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (lumpy Knot at injection site on my arm that hurts) and VACCINATION SITE PAIN (lumpy Knot at injection site on my arm that hurts). At the time of the report, VACCINATION SITE MASS (lumpy Knot at injection site on my arm that hurts) and VACCINATION SITE PAIN (lumpy Knot at injection site on my arm that hurts) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided. Treatment information was not reported.
Pt has fatigue, fever, chills, athritis, orchitis and headache after receiving vacination last over a week. He was seen today at Family Practice.
Verbalize red rash on neck and chest.  Was evaluated by Fire Rescue and MD on site and released home at 11:37 am feeling better.
wheezing; breathing hard for every step; sweating a lot / perspiration; dizzy/Light headed; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (breathing hard for every step), HYPERHIDROSIS (sweating a lot / perspiration), DIZZINESS (dizzy/Light headed) and WHEEZING (wheezing) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac) (had Pacemaker surgery in his heart) on 12-Apr-2021. Concurrent medical conditions included Lung cancer and Cholesterol. Concomitant products included DICLOFENAC for Arthritis, ROSUVASTATIN for Cholesterol, FINASTERIDE, VITAMIN D3, CURCUMA LONGA (TURMERIC CURCUMIN [CURCUMA LONGA]), FISH OIL (OMEGA 3 FISH OILS) and APPLE CIDER VINEGAR for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DYSPNOEA (breathing hard for every step), HYPERHIDROSIS (sweating a lot / perspiration) and DIZZINESS (dizzy/Light headed). On an unknown date, the patient experienced WHEEZING (wheezing). The patient was treated with PREDNISONE from 11-May-2021 to 16-May-2021 at a dose of 50 milligram and GENTAMICIN from 11-May-2021 to 16-May-2021 at a dose of 250 milligram. At the time of the report, DYSPNOEA (breathing hard for every step), HYPERHIDROSIS (sweating a lot / perspiration), DIZZINESS (dizzy/Light headed) and WHEEZING (wheezing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97.7 (normal) Body temperature recorded as 97.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional Treatment information includes patient taking Nebulizer 2-3 times a day.A  Additional lab data includes numerous tests such as CT Head & Brain w/o Contrast, Chest x-ray(2 views), CT chest w/o contrast, CT Head and neck, HbA1C, B-Type natriuretic peptide, Lipid Panel, MRI Brain, TSH, INR, Hepatic function panel, Basic metabolic panel, CBC with differential, SARS-COV 2 Ag, ECG all for an Unknown dates with Inconclusive results. Patient provided information for a particular adverse event on 14 March 2021 saying he did not felt right and still continues.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jun-2021: Follow up document received on 12-JUN-2021 contains No New Information. On 18-Jun-2021: Followup document received on 18-jun-2021 contains No New Information. On 24-Jul-2021: Follow-up received on 24 July 2021 and contains significant information where Patient details, Medical history, Treatment information, concomitant product information, Laboratory data all were provided.
Immediately after receiving vaccines (HPV), patients eyes rolled back slight and she became rigid, lasting less than 10 seconds. No tonic-clonic movement. Was slightly confused initially then awoke and appropriate with stable vitals. Sitting up drinking water and juice and speaking appropriately. Felt fine after 15 min's and discharged home.
patient recievd flu vaccine at MD office and Shingrix vaccine at pharmacy within 2 days apart. Pt experienced redness and mild swelling at injection site
Patient received the shot Monday afternoon around 134pm then called the pharmacy on Wednesday September 12th in the later afternoon. I was unavailable and didn't want to speak with the other pharmacist. I spoke to the pt. early Thursday morning when she presented to the pharmacy with a red, swollen arm. The arm didn't look "angry" or feel hot. There was a bruise in the middle of her left deltoid indicating the shot wasn't given too high or too low. I explained that if she had previously had the PREVNAR or PNEUMOVAX this type of reaction may occur. I told her to keep an eye on it to make sure it doesn't get worse, keep it elevated, use an occasional ice bag to reduce swelling and unless told otherwise by provider; use acetaminophen. I also instructed her to call me if her symptoms don't improve.